Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for ATEC

Stock Name	Alphatec Holdings Inc
Ticker	ATEC(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US02081G2012
LEI	549300EZE8CQ8K65FS24

Show aggregate ATEC holdings

News associated with ATEC

Alphatec (NASDAQ:ATEC) EVP Sells $2,074,045.05 in Stock: Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) EVP David Sponsel sold 137,445 shares of Alphatec stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $15.09, for a total value of $2,074,045.05. Following the completion of the sale, the executive vice president owned 534,416 shares […] - 2025-09-22 05:13:23
Deutsche Bank AG Has $12.02 Million Stock Holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC): Deutsche Bank AG grew its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 11.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 1,185,235 shares of the medical technology company’s stock after acquiring an additional 124,785 shares during the period. Deutsche Bank AG’s holdings in Alphatec were worth $12,018,000 at the end […] - 2025-08-15 05:17:11
Mitsubishi UFJ Asset Management Co. Ltd. Has $413,000 Stock Position in Alphatec Holdings, Inc. (NASDAQ:ATEC): Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 4.6% in the first quarter, Holdings Channel.com reports. The firm owned 40,734 shares of the medical technology company’s stock after acquiring an additional 1,792 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Alphatec […] - 2025-08-14 05:32:58
Alphatec (NASDAQ:ATEC) Upgraded by Wall Street Zen to Buy Rating: Alphatec (NASDAQ:ATEC – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday. Several other analysts have also weighed in on ATEC. Barclays reissued an “overweight” rating and issued a $22.00 price objective (up from $21.00) on shares of […] - 2025-08-11 03:58:50
Alphatec (NASDAQ:ATEC) Sets New 52-Week High – Here’s Why: Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Saturday . The stock traded as high as $13.89 and last traded at $13.77, with a volume of 12995953 shares traded. The stock had previously closed at $10.58. Analyst Upgrades and Downgrades Several research analysts have […] - 2025-08-04 02:36:43
KLP Kapitalforvaltning AS Sells 5,900 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC): KLP Kapitalforvaltning AS trimmed its position in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 23.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 18,900 shares of the medical technology company’s stock after selling 5,900 shares during the period. KLP Kapitalforvaltning AS’s holdings in Alphatec were worth […] - 2025-08-01 04:18:59
Alphatec Holdings, Inc. (NASDAQ:ATEC) COO Scott Lish Sells 3,982 Shares: Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) COO Scott Lish sold 3,982 shares of the company’s stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $12.00, for a total transaction of $47,784.00. Following the completion of the sale, the chief operating officer directly owned 744,936 shares […] - 2025-07-15 06:21:01
Oppenheimer Asset Management Inc. Buys 1,552 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC): Oppenheimer Asset Management Inc. increased its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 13.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,144 shares of the medical technology company’s stock after purchasing an additional 1,552 shares during […] - 2025-07-02 04:40:53
Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives $17.89 Consensus Price Target from Analysts: Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year target price […] - 2025-06-25 03:02:53
Alphatec (NASDAQ:ATEC) Upgraded at Lake Street Capital: Alphatec (NASDAQ:ATEC – Get Free Report) was upgraded by research analysts at Lake Street Capital to a “buy” rating in a research note issued on Monday, Marketbeat Ratings reports. The brokerage presently has a $18.00 target price on the medical technology company’s stock. Lake Street Capital’s price objective would indicate a potential upside of 65.90% […] - 2025-06-18 02:36:46
Alphatec (NASDAQ:ATEC) Shares Down 6.5% Following Insider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) shares fell 6.5% on Monday after an insider sold shares in the company. The company traded as low as $12.26 and last traded at $11.91. 437,565 shares traded hands during trading, a decline of 79% from the average session volume of 2,038,856 shares. The stock had previously […] - 2025-06-11 02:08:45
Procyon Advisors LLC Purchases 4,769 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC): Procyon Advisors LLC grew its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 14.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 37,581 shares of the medical technology company’s stock after buying an additional 4,769 shares during the quarter. Procyon Advisors LLC’s holdings in Alphatec were worth $381,000 at the […] - 2025-06-09 05:52:53
Insider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Sells 186,122 Shares of Stock: Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) EVP Craig E. Hunsaker sold 186,122 shares of Alphatec stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $12.34, for a total value of $2,296,745.48. Following the completion of the transaction, the executive vice president now directly owns 1,463,896 […] - 2025-06-09 05:08:51
Squarepoint Ops LLC Reduces Stock Holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC): Squarepoint Ops LLC lessened its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 89.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 50,959 shares of the medical technology company’s stock after selling 412,342 shares during the quarter. Squarepoint Ops LLC’s holdings in Alphatec were worth $468,000 at the end […] - 2025-06-05 05:16:59
Alphatec Holdings, Inc. (NASDAQ:ATEC) Given Consensus Recommendation of “Moderate Buy” by Brokerages: Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 […] - 2025-05-28 02:34:51
Lazard Asset Management LLC Purchases New Position in Alphatec Holdings, Inc. (NASDAQ:ATEC): Lazard Asset Management LLC acquired a new stake in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 8,348 shares of the medical technology company’s stock, valued at approximately $76,000. Several other institutional investors have also added to or reduced their stakes in ATEC. R Squared Ltd […] - 2025-05-26 04:50:56
Comerica Bank Boosts Position in Alphatec Holdings, Inc. (NASDAQ:ATEC): Comerica Bank boosted its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 66.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,116 shares of the medical technology company’s stock after purchasing an additional 1,248 shares during the quarter. Comerica Bank’s holdings in Alphatec were worth $29,000 as of its […] - 2025-05-20 04:28:54
BNP Paribas Financial Markets Grows Position in Alphatec Holdings, Inc. (NASDAQ:ATEC): BNP Paribas Financial Markets increased its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 1,665.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 381,324 shares of the medical technology company’s stock after purchasing an additional 359,721 shares during the quarter. BNP Paribas Financial Markets’ holdings in Alphatec were worth […] - 2025-05-15 05:36:54
Schonfeld Strategic Advisors LLC Sells 82,356 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC): Schonfeld Strategic Advisors LLC decreased its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 75.8% in the 4th quarter, Holdings Channel reports. The firm owned 26,300 shares of the medical technology company’s stock after selling 82,356 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Alphatec were worth $241,000 at […] - 2025-05-14 04:54:50
Stifel Financial Corp Trims Stock Holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC): Stifel Financial Corp lessened its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 154,167 shares of the medical technology company’s stock after selling 24,535 shares during […] - 2025-05-08 05:16:49
Financial Survey: Alphatec (NASDAQ:ATEC) versus MiMedx Group (NASDAQ:MDXG): Alphatec (NASDAQ:ATEC – Get Free Report) and MiMedx Group (NASDAQ:MDXG – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 66.3% of Alphatec shares […] - 2025-05-08 02:40:05
Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives $17.89 Consensus Price Target from Analysts: Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 […] - 2025-05-06 03:07:08
MetLife Investment Management LLC Purchases 3,719 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC): MetLife Investment Management LLC lifted its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 6.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,274 shares of the medical technology company’s stock after purchasing an additional 3,719 shares during the […] - 2025-05-05 06:00:53
Piper Sandler Reiterates “Overweight” Rating for Alphatec (NASDAQ:ATEC): Piper Sandler restated their overweight rating on shares of Alphatec (NASDAQ:ATEC – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a $15.00 target price on the medical technology company’s stock, up from their previous target price of $13.00. Several other equities research analysts have also recently […] - 2025-05-05 05:06:44
Legal & General Group Plc Buys 3,529 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC): Legal & General Group Plc lifted its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 3.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 113,417 shares of the medical technology company’s stock after acquiring an additional 3,529 shares during the period. Legal & General Group Plc’s holdings in Alphatec were […] - 2025-04-28 04:55:06
Renaissance Technologies LLC Grows Stock Position in Alphatec Holdings, Inc. (NASDAQ:ATEC): Renaissance Technologies LLC increased its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 106.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 292,100 shares of the medical technology company’s stock after buying an additional 150,500 shares during […] - 2025-04-25 05:23:10
HC Wainwright Reiterates Buy Rating for Alphatec (NASDAQ:ATEC): Alphatec (NASDAQ:ATEC – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $20.00 target price on the medical technology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 101.82% from the company’s […] - 2025-04-16 02:28:55
39,028 Shares in Alphatec Holdings, Inc. (NASDAQ:ATEC) Bought by Raymond James Financial Inc.: Raymond James Financial Inc. bought a new stake in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 39,028 shares of the medical technology company’s stock, valued at approximately $358,000. Several other […] - 2025-04-10 04:14:53
Alphatec Holdings, Inc. (NASDAQ:ATEC) Shares Sold by Corebridge Financial Inc.: Corebridge Financial Inc. lowered its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 5.7% during the fourth quarter, Holdings Channel reports. The fund owned 51,755 shares of the medical technology company’s stock after selling 3,136 shares during the quarter. Corebridge Financial Inc.’s holdings in Alphatec were worth $475,000 at the end […] - 2025-04-09 04:38:47
Alphatec Holdings, Inc. (NASDAQ:ATEC) Stock Position Lifted by CIBC Private Wealth Group LLC: CIBC Private Wealth Group LLC lifted its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 19.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,154 shares of the medical technology company’s stock after purchasing an additional […] - 2025-04-07 05:13:09

iShares US Medical Devices UCITS ETF ATEC holdings

Date	Number of ATEC Shares Held	Base Market Value of ATEC Shares	Local Market Value of ATEC Shares	Change in ATEC Shares Held	Change in ATEC Base Value	Current Price per ATEC Share Held	Previous Price per ATEC Share Held
2025-09-26 (Friday)	16,100	USD 241,822	USD 241,822
2025-09-25 (Thursday)	16,100	USD 247,779	USD 247,779
2025-09-24 (Wednesday)	15,108	USD 229,793	USD 229,793
2025-09-18 (Thursday)	13,971	USD 212,639	USD 212,639	0	USD 7,265	USD 15.22	USD 14.7
2025-09-17 (Wednesday)	13,971	USD 205,374	USD 205,374	0	USD -4,610	USD 14.7	USD 15.03
2025-09-16 (Tuesday)	13,971	USD 209,984	USD 209,984
2025-09-15 (Monday)	13,971	USD 210,264	USD 210,264
2025-09-12 (Friday)	13,971	USD 213,197	USD 213,197
2025-09-11 (Thursday)	13,971	USD 218,367	USD 218,367

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ATEC by Blackrock for IE00BMX0DF60

Show aggregate share trades of ATEC

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-06-27 SELL -236 11.080* 10.56 Profit of 2,492 on sale
2025-06-12 BUY 351 11.370* 10.53
2025-06-10 SELL -1,840 12.210* 10.50 Profit of 19,325 on sale
2025-06-09 SELL -2,185 11.920* 10.49 Profit of 22,925 on sale
2025-05-30 SELL -228 12.430* 10.40 Profit of 2,370 on sale
2025-05-19 BUY 114 13.030* 10.22
2025-05-16 BUY 1,378 12.960* 10.20
2025-05-09 SELL -570 12.210* 10.09 Profit of 5,749 on sale
2025-04-23 SELL -115 11.210* 9.89 Profit of 1,137 on sale
2025-04-17 SELL -115 10.560* 9.86 Profit of 1,134 on sale
2025-04-10 BUY 904 9.530* 9.85
2025-04-04 SELL -226 10.230* 9.85 Profit of 2,226 on sale
2025-04-02 SELL -226 10.450* 9.84 Profit of 2,225 on sale
2025-03-31 SELL -339 10.140* 9.84 Profit of 3,335 on sale
2025-03-19 SELL -109 9.540* 9.80 Profit of 1,069 on sale
2025-02-28 SELL -214 12.530* 9.68 Profit of 2,071 on sale
2025-02-05 BUY 339 11.950* 9.15
2025-02-04 BUY 452 12.140* 9.08
2025-01-29 SELL -113 12.060* 8.80 Profit of 994 on sale
2025-01-23 SELL -114 11.670* 8.50 Profit of 969 on sale
2025-01-02 SELL -210 9.060* 8.48 Profit of 1,782 on sale
2024-12-04 BUY 309 10.050* 8.27
2024-12-03 SELL -107 10.000* 8.20 Profit of 878 on sale
2024-12-02 SELL -1,296 10.210* 8.13 Profit of 10,530 on sale
2024-11-29 SELL -2,180 10.480* 8.03 Profit of 17,508 on sale
2024-11-27 SELL -327 10.370* 7.83 Profit of 2,560 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-06-27	SELL	-236	11.080*	10.56 Profit of 2,492 on sale
2025-06-12	BUY	351	11.370*	10.53
2025-06-10	SELL	-1,840	12.210*	10.50 Profit of 19,325 on sale
2025-06-09	SELL	-2,185	11.920*	10.49 Profit of 22,925 on sale
2025-05-30	SELL	-228	12.430*	10.40 Profit of 2,370 on sale
2025-05-19	BUY	114	13.030*	10.22
2025-05-16	BUY	1,378	12.960*	10.20
2025-05-09	SELL	-570	12.210*	10.09 Profit of 5,749 on sale
2025-04-23	SELL	-115	11.210*	9.89 Profit of 1,137 on sale
2025-04-17	SELL	-115	10.560*	9.86 Profit of 1,134 on sale
2025-04-10	BUY	904	9.530*	9.85
2025-04-04	SELL	-226	10.230*	9.85 Profit of 2,226 on sale
2025-04-02	SELL	-226	10.450*	9.84 Profit of 2,225 on sale
2025-03-31	SELL	-339	10.140*	9.84 Profit of 3,335 on sale
2025-03-19	SELL	-109	9.540*	9.80 Profit of 1,069 on sale
2025-02-28	SELL	-214	12.530*	9.68 Profit of 2,071 on sale
2025-02-05	BUY	339	11.950*	9.15
2025-02-04	BUY	452	12.140*	9.08
2025-01-29	SELL	-113	12.060*	8.80 Profit of 994 on sale
2025-01-23	SELL	-114	11.670*	8.50 Profit of 969 on sale
2025-01-02	SELL	-210	9.060*	8.48 Profit of 1,782 on sale
2024-12-04	BUY	309	10.050*	8.27
2024-12-03	SELL	-107	10.000*	8.20 Profit of 878 on sale
2024-12-02	SELL	-1,296	10.210*	8.13 Profit of 10,530 on sale
2024-11-29	SELL	-2,180	10.480*	8.03 Profit of 17,508 on sale
2024-11-27	SELL	-327	10.370*	7.83 Profit of 2,560 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ATEC

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	224,507	1,900	530,224	42.3%
2025-09-18	357,066	0	684,843	52.1%
2025-09-17	233,977	0	554,510	42.2%
2025-09-16	269,776	100	535,776	50.4%
2025-09-15	159,144	0	439,581	36.2%
2025-09-12	241,673	0	494,701	48.9%
2025-09-11	387,048	0	787,365	49.2%
2025-09-10	296,350	500	617,453	48.0%
2025-09-09	246,527	152	685,568	36.0%
2025-09-08	291,270	49	512,106	56.9%
2025-09-05	133,128	0	365,978	36.4%
2025-09-04	343,360	50	1,082,015	31.7%
2025-09-03	186,147	0	631,137	29.5%
2025-09-02	170,806	0	461,673	37.0%
2025-08-29	183,953	0	520,473	35.3%
2025-08-28	527,354	0	1,147,725	45.9%
2025-08-27	143,402	0	594,815	24.1%
2025-08-26	167,637	3,576	696,981	24.1%
2025-08-25	124,060	1,000	501,532	24.7%
2025-08-22	125,059	0	733,770	17.0%
2025-08-21	154,943	229	717,454	21.6%
2025-08-20	175,867	0	461,259	38.1%
2025-08-19	450,547	217,200	1,081,387	41.7%
2025-08-18	363,376	99,100	661,427	54.9%
2025-08-15	224,609	12,943	532,553	42.2%
2025-08-14	177,467	0	473,697	37.5%
2025-08-13	302,800	97,800	697,768	43.4%
2025-08-12	617,773	218,100	1,094,412	56.4%
2025-08-11	305,442	121,958	905,251	33.7%
2025-08-08	170,531	0	626,261	27.2%
2025-08-07	395,066	7,328	1,014,166	39.0%
2025-08-06	469,858	13,848	1,292,346	36.4%
2025-08-05	748,346	200	2,423,153	30.9%
2025-08-04	1,339,278	19,700	3,903,842	34.3%
2025-08-01	3,400,225	16,450	6,664,223	51.0%
2025-07-31	921,776	944	1,291,427	71.4%
2025-07-30	203,588	0	387,846	52.5%
2025-07-29	262,718	0	452,861	58.0%
2025-07-28	563,018	0	772,519	72.9%
2025-07-25	148,636	217	293,721	50.6%
2025-07-24	132,083	0	253,711	52.1%
2025-07-23	134,118	500	309,054	43.4%
2025-07-22	265,040	500	501,977	52.8%
2025-07-21	307,751	20,266	523,866	58.7%
2025-07-18	123,457	0	307,023	40.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam